References
- Al-HerzWBousfihaACasanovaJLPrimary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for Primary ImmunodeficiencyFront Immun2011254
- McCuskerCWarringtonRPrimary immunodeficiencyAllergy Asthma Clin Immunol20117Suppl 1S1122165913
- NotarangeloLDPrimary immunodeficienciesJ Allergy Clin Immunol20101252 Suppl 2S182S19420042228
- Cunningham-RundlesCKey aspects for successful immunoglobulin therapy of primary immunodeficienciesClin Exp Immunol2011164Suppl 2161921466548
- MisbahSSturzeneggerMHBorteMSubcutaneous immunoglobulin: opportunities and outlookClin Exp Immunol2009158Suppl 1515919883424
- BergerMSubcutaneous immunoglobulin replacement in primary immunodeficienciesClin Immunol20041121715207776
- GardulfAImmunoglobulin treatment for primary antibody deficiencies: advantages of the subcutaneous routeBio Drugs200721105116
- Skoda-SmithSTorgersonTROchsHDSubcutaneous immunoglobulin replacement therapy in the treatment of patients with primary immunodeficiency diseaseTher Clin Risk Manag2010611020169031
- WoodPHuman normal immunoglobulin in the treatment of primary immunodeficiency diseasesTher Clin Risk Manag2012815716722547934
- MohamedAFKilambiVLuoMPIyerRGLi-McLeodJMPatient and parent preferences for immunoglobulin treatments: a conjoint analysisJ Med Econ20121519
- QualityMetricSF-12v2 health survey Available from: http://www.qualitymetric.com/WhatWeDo/SFHealthSurveys/SF12v2HealthSurvey/tabid/186/Default.aspxAccessed May 7, 2013
- QualityMetricSF-10 Health Survey for Children Available from: http://www.qualitymetric.com/WhatWeDo/PediatricHealthSurveys/SF10HealthSurveyforChildren/tabid/195/Default.aspxAccessed February 28, 2014
- EuroQol GroupAbout EQ-5D Available from: http://www.euroqol.org/about-eq-5d.htmlAccessed December 23, 2013
- McFaddenDTrainKMixed MNL models of discrete responseJ Appl Econ200015447470
- HauberABMohamedAFJohnsonFRMeddisDWagnerSO’DowdLQuantifying asthma patient preferences for onset of effect of combination inhaled corticosteroids and long-acting beta2-agonist maintenance medicationsAllergy Asthma Proc20093013914719463204
- HauberABMohamedAFWatsonMEJohnsonFRHernandezJEBenefits, risks and uncertainty: references of antiretroviral-naive African Americans for HIV treatmentAIDS Patient Care STDS200923293419113949
- MohamedAFHauberABNearyMPPatient benefit-risk preferences for targeted agents in the treatment of renal cell carcinomaPharmacoeconomics20112997798821854079
- WareJEKosinskiMTurner-BowkerDMGandekBHow to Score Version 2 of the SF-12 Health SurveyLincoln, RI, USAQualityMetric Inc2002
- GardulfANicolayUMathDChildren and adults with primary antibody deficiencies gain quality of life by subcutaneous IgG self-infusions at homeJ Allergy Clin Immunol200411493694215480339
- International Patient Organisation for Primary ImmunodeficienciesPosition statement: access to immunoglobulin therapies for patients living with a primary immunodeficiency2012 Available from: http://www.ipopi.org/index.php?mact=News,cntnt01,detail,0&cntnt01articleid=218&cntnt01origid=38&cntnt01detailtemplate=detalj&cntnt01returnid=63Accessed May 7, 2013
- AbolhassaniHSadaghianiMSAghamohammadiAOchsHDRezaeiNHome-based subcutaneous immunoglobulin versus hospital-based intravenous immunoglobulin in treatment of primary antibody deficiencies: systematic review and meta analysisJ Clin Immunol2012321180119222730009
- GardulfAAndersenVBjörkanderJSubcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: safety and costsLancet19953453653697845120
- ChapelHMSpickettGPEricsonDEnglWEiblMMBjorkanderJThe comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapyJ Clin Immunol2000209410010821460
- GarcíaJMEspañolTGurbindoMDCasasCCUpdate on the treatment of primary immunodeficienciesAllergol Immunopathol (Madr)20073518419217923072
- BonillaFAIntravenous immunoglobulin: adverse reactions and managementJ Allergy Clin Immunol20081221238123918842292
- Immune Deficiency FoundationPrimary immunodeficiency diseases in America: 2007The third national survey of patients2009 Available from: http://primaryimmune.org/about-primary-immunodeficiency-diseases/idf-publications?aid-1264&pid=275&sa=1Accessed May 7, 2013
- BonillaFAIgG replacement therapy, no size fits allJ Clin Immunol2011139107109
- OrangeJSClinical update in immunoglobulin therapy for primary immunodeficiency diseasesClinical Focus on Primary Immunodeficiencies20111419 Available from: http://primaryimmune.org/wp-content/uploads/2011/04/Clinical-Update-in-Immunoglobulin-Therapy-for-Primary-Immunodeficiency-Diseases.pdfAccessed December 23, 2013
- CrawfordBDalalAAStanfordRBaylissMSLimJPhilpotEValidation of the Experience with Allergic Rhinitis Nasal Spray Questionnaire (EARNS_Q): a patient reported outcomes (PRO) questionnaire to measure experience and preference with nasal spraysJ Allergy Clin Immunol20081212 SupplS106
- FasthANyströmJQuality of life and health-care resource utilization among children with primary immunodeficiency receiving home treatment with subcutaneous human immunoglobulinJ Clin Immunol20082837037818256911
- NavarroRPBallowMFenrickBPezallaEJConsiderations for the optimal use of immunoglobulinAm J Manag Care2012184 SupplS67S7822774920